The United Kingdom national rare donor panel
Thornton, N.M.
Development of red blood cell autoantibodies following treatment with checkpoint inhibitors: a new class of anti-neoplastic, immunotherapeutic agents associated with immune dysregulation
Cooling, L.L.W., Sherbeck, J., Mowers, J.C., Hugan, S.L.
Erratum
Hemovigilance and the Notify Library
Whitaker, B.I., Strong, D.M., Gandhi, M.J., Petrisli, E.
Anti-Vel alloimmunization and severe hemolytic disease of the fetus and newborn
Moise, K.J., Morales, Y., Bertholf, M.F., Rossmann, S.N., Bai, Y.
Red blood cell phenotype prevalence in blood donors who self-identify as Hispanic
Sheppard, C.A., Bolen, N.L., Eades, B., Ochoa-Garay, G., Yazer, M.H.
Separation of multiple antibodies by adsorption with allogeneic red blood cells
Ekema, E.M.
DEL phenotype
Kwon, D.H., Sandler, S.G., Flegel, W.A.
Use of standard laboratory methods to obviate routine dithiothreitol treatment of blood samples with daratumumab interference
Lintel, N.J., Brown, D.K., Schafer, D.T., Tsimba-Chitsva, F.M., Koepsell, S.A., Shunkwiler, S.M.
Cover_TOC_Masthead - ISSUE 1/2017
The FORS awakens: review of a blood group system reborn
Hult, A.K., Olsson, M.L.
The Vel blood group system: a review
Storry, J.R., Peyrard, T.